Z-2358-2020 Class II Terminated
FDA device recall Z-2358-2020 was initiated by Becton, Dickinson And Company, BD Biosciences on Jul 8, 2019 and is designated Class II. Reason for recall: The recalling firm confirmed that SPA II and III users may encounter probes with unacceptable wear prior to reaching the 2500 piercings guideline indicated in the Instructions for Use (IFU). When… The recall status is terminated (terminated Jan 31, 2023). Affected quantity: 467 units.
Recall details
- Product Type
- Devices
- Report Date
- Jun 17, 2020
- Initiation Date
- Jul 8, 2019
- Termination Date
- Jan 31, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 467 units
Product description
Reason for recall
Distribution pattern
Worldwide distribution - US Nationwide distribution including in the states of AL, CO,CT, GA, IL, MA, MI, MD, NC, NH,NJ, NY, OH, PA, TN, TX, VA, and VT. The countries of Australia, Botswana, Brazil, Canada, Chile, China, Colombia, Costa Rica, Europe, Hong Kong, India, Italy, Jamaica, Japan, Kazakhstan, Malaysia, Martinique, Mexico, New Zealand, Nicaragua, Peru, Puerto Rico (US), Romania, Russia, Singapore, South Africa, South Korea, Swaziland, Switzerland, Turkey, US, Vietnam.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2358-2020
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026